@rbreich What percentage of that price goes towards profit, and what percentage goes towards recouping for the CapEx costs, particularly the *billions* of dollars spend on unnecessary, overly complicated, bureaucratic, regulatory approval processes? What percentage of the price goes towards recouping the development costs of other drugs that didn’t end up working as intended, and so were never sold? The OpEx costs and the price says nothing about the real underlying cost structure